GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (NYSE:EW) » Definitions » Cyclically Adjusted PB Ratio

EW (Edwards Lifesciences) Cyclically Adjusted PB Ratio : 8.72 (As of Jul. 19, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted PB Ratio?

As of today (2025-07-19), Edwards Lifesciences's current share price is $76.49. Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $8.77. Edwards Lifesciences's Cyclically Adjusted PB Ratio for today is 8.72.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

EW' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7.9   Med: 15.49   Max: 26.56
Current: 8.69

During the past years, Edwards Lifesciences's highest Cyclically Adjusted PB Ratio was 26.56. The lowest was 7.90. And the median was 15.49.

EW's Cyclically Adjusted PB Ratio is ranked worse than
91.35% of 497 companies
in the Medical Devices & Instruments industry
Industry Median: 1.9 vs EW: 8.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Edwards Lifesciences's adjusted book value per share data for the three months ended in Mar. 2025 was $17.279. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $8.77 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted PB Ratio Chart

Edwards Lifesciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.83 25.42 12.18 10.75 8.87

Edwards Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.84 12.00 8.22 8.87 8.27

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PB Ratio falls into.


;
;

Edwards Lifesciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Edwards Lifesciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=76.49/8.77
=8.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Edwards Lifesciences's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=17.279/134.9266*134.9266
=17.279

Current CPI (Mar. 2025) = 134.9266.

Edwards Lifesciences Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.552 100.684 4.760
201509 3.747 100.392 5.036
201512 3.874 99.792 5.238
201603 3.617 100.470 4.857
201606 3.873 101.688 5.139
201609 4.199 101.861 5.562
201612 4.126 101.863 5.465
201703 4.345 102.862 5.699
201706 4.642 103.349 6.060
201709 4.982 104.136 6.455
201712 4.699 104.011 6.096
201803 5.135 105.290 6.580
201806 5.042 106.317 6.399
201809 5.358 106.507 6.788
201812 5.040 105.998 6.416
201903 5.514 107.251 6.937
201906 5.612 108.070 7.007
201909 6.099 108.329 7.596
201912 6.613 108.420 8.230
202003 6.297 108.902 7.802
202006 6.178 108.767 7.664
202009 6.759 109.815 8.305
202012 7.327 109.897 8.996
202103 7.492 111.754 9.045
202106 8.238 114.631 9.697
202109 8.877 115.734 10.349
202112 9.351 117.630 10.726
202203 9.406 121.301 10.463
202206 9.590 125.017 10.350
202209 10.038 125.227 10.816
202212 9.546 125.222 10.286
202303 9.865 127.348 10.452
202306 10.488 128.729 10.993
202309 10.977 129.860 11.405
202312 11.063 129.419 11.534
202403 11.816 131.776 12.098
202406 12.348 132.554 12.569
202409 16.184 133.029 16.415
202412 16.987 133.157 17.213
202503 17.279 134.927 17.279

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (NYSE:EW) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Edwards Lifesciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Executives
Daveen Chopra officer: CVP, Surgical Structural Heart C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92618
Scott B. Ullem officer: CVP, CFO C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Wayne Markowitz officer: GM & SVP, Surgical ONE EDWARDS WAY, IRVINE CA 92614
Bernard J Zovighian officer: CVP, Surgical Heart Valves C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Bobo Donald E Jr officer: CVP,Strategy/Corp Development C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614
Steven R Loranger director XYLEM. INC., 1133 WESTCHESTER AVENUE, WHITE PLAINS NY 10604
Heisz Leslie Stone director C/O PUBLIC STORAGE, 701 WESTERN AVENUE, GLENDALE CA 91201
Larry L Wood officer: CVP, THV Replacement C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Michael A Mussallem director, officer: Chairman & CEO C/O EDWARDS LIFESCIENCES CORP, ONE EDWARDS WAY, IRVINE CA 92614
Jean-luc M Lemercier officer: CVP, EMEA, Canada, Latin Amer C/O ONE EDWARDS WAY, IRVINE CA 92614
Kieran Gallahue director PO BOX 684369, PARK CITY UT 84068
Catherine M. Szyman officer: CVP, Critical Care C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sellers Robert W.a. officer: VP, Corp. Controller (Principa ONE EDWARDS WAY, IRVINE CA 92614
Huimin Wang officer: CVP, Japan & Intercontinental C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614
Martha H. Marsh director 9769 WEXFORD CIRCLE, GRANITE BAY CA 95746